BG
Highly rated in
14
conditions
Highly rated in
14
conditions
Check Dr. Benjamin M. Greenberg's experience treating your condition:
About Dr. Benjamin M. Greenberg

Benjamin Greenberg is a Neurologist in Dallas, Texas. Greenberg has been practicing medicine for over 21 years and is highly rated in 14 conditions, according to our data. His top areas of expertise are Optic Neuritis, Neuromyelitis Optica, Transverse Myelitis, and Multiple Sclerosis. He is licensed to treat patients in Texas and Maryland. Greenberg is currently accepting new patients.

His clinical research consists of co-authoring 181 peer reviewed articles and participating in 10 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Benjamin M. Greenberg it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Benjamin M. Greenberg accepts the following insurance:

  •  Ambetter

Call to see if your plan is accepted.
Locations
5303 Harry Hines Blvd, Dallas, TX 75390
Other Locations
2350 N Stemmons Fwy, Dallas, TX 75207
1935 Medical District Dr, Dallas, TX 75235
Background & Education
Graduate Institution
Baylor College Of Medicine, 2001
Specialties
Neurology
Licenses
Psychiatry & Neurology in MD
Hospital Affiliations
Parkland Health And Hospital System
CHRISTUS Mother Frances Hospital - Winnsboro
William P Clements Jr University Hospital
Baylor Scott & White Institute For Rehabilitation - Dallas
Childrens Medical Center Dallas
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


10 Clinical Trials

A Multicenter Randomized Controlled Trial of Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Treatment-Resistant Relapsing Multiple Sclerosis (ITN077AI)
Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis
Phase 1 Intrathecal Lumbar Administration of AAV9/CLN7 for Treatment of CLN7 Disease
Effect of MD1003 in Progressive Multiple Sclerosis: a Randomized Double Blind Placebo Controlled Study
View 5 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors